It is time to reconsider leukoreduction of whole blood for use in patients with life-threatening hemorrhage.

Saved in:
Bibliographic Details
Title: It is time to reconsider leukoreduction of whole blood for use in patients with life-threatening hemorrhage.
Authors: Yazer MH; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Beckett A; Canadian Forces Health Services, Ottawa, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Bloch EM; Johns Hopkins University School of Medicine, Department of Pathology, Baltimore, Maryland, USA., Cap AP; Department of Medicine, Uniformed Services University, Bethesda, Maryland, USA., Cohn CS; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.; Association for the Advancement of Blood and Biotherapies (AABB), Bethesda, Maryland, USA., Gurney J; Department of Surgery, Brook Army Medical Center, San Antonio, Texas, USA., Hermelin D; ImpactLife, Davenport, Iowa, USA.; Department of Pathology, St. Louis University School of Medicine, St. Louis, Missouri, USA., Spinella PC; Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Source: Transfusion [Transfusion] 2024 Dec; Vol. 64 (12), pp. 2391-2399. Date of Electronic Publication: 2024 Oct 17.
Publication Type: Journal Article
Journal Info: Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-2995
DOI:10.1111/trf.18047